Article and Video CATEGORIES
We are excited to launch our second year of this program - Patient Perspectives - Clinical Trials Experiences Through Storytelling
GRACE’s mission is to provide expert-mediated information directly to cancer patients and their caregivers to empower them to become direct partners in their cancer treatment. The Clinical Trials Experiences Through Storytelling program helps patients to become educators and to help others learn about the journey they may be beginning or continuing on. To apply online please click here.
GRACE Patient Perspectives: Clinical Trials Experiences Storytelling Program Overview
The goal of this program is to give a voice to patients with experience in participating in a clinical trial, in order to provide patient education for others through storytelling.
Through storytelling and sharing their experience, patients can educate others who are considering a clinical trial about this aspect of the cancer journey. Storytelling will take the form of written, video, and/or audio/podcast to reach the largest patient audience.
All cancer patients currently enrolled in, or with past enrollment in a clinical trial are welcomed and encouraged to apply. GRACE’s designated committee will review the nominees and select up to 3 participants for the honor of participating in the 2022-23 program.
Benefits of Participation
Patients selected for this year’s program will work closely with GRACE to develop new educational content for patients across a range of platforms that will help them become established contributors in the area of advocacy.
Participants will receive training on digitally distributed content and social media, and their work will be highlighted and shared by the internationally recognized non-profit GRACE, along with its network of established leaders in the oncology community and board members with an array of interests and connections.
Participants will receive a stipend, training in communication and media platforms, and a tech ‘package’. Participants will work with GRACE to develop program formats and production and will present a proposal based on their area of experience in a clinical trial program. Participants will be expected to attend (via ZOOM) regular meetings throughout the program year to learn and discuss their ideas. A minimum of three (3) media productions per participant will be expected by the end of the program. Our goal is to learn from each other.
2022 is our second year for this program, and we are excited to generate a platform for patient advocacy and sharing patient education in the area of clinical trials.
Patients dealing with a cancer diagnosis that are currently or have been involved in a clinical trial and who have a passion for helping others and for telling their stories are ideal for this program. Applicants should have a particular interest and passion for communications, sharing experiences/storytelling, patient education, and looking for a way to give back to the cancer community. Patients with strong written and oral communication skills coupled with a passion for sharing experiences in order to educate and advocate will thrive in this program. GRACE will guide them through boosting their voice to help the cancer patient community.
All application forms must be submitted by July 30, 2022, for consideration. Applicants will be contacted by August 15, 2022, with information regarding acceptance and any next steps.
To apply online please click here OR download the above attached pdf form and email it to dbrock@cancerGRACE.org.
Any questions, please contact firstname.lastname@example.org or 888-501-1025 x2.
Please feel free to offer comments and raise questions in our
Next Previous linkPrevious PostNext Post
Hi Caregiver and welcome to Grace. I'm sorry that you need to be here and hope we can help. Osimertinib has better efficacy than gefitinib (including OS and reaching the brain)...
Hi Bob, Welcome to Grace. I'm sorry about your sil. Unfortunately, cancer becomes resistant to TKIs like tagrisso. Sometimes all of the cancer becomes resistant at once and sometimes just parts...